Growth Metrics

Novartis Ag (NVS) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Novartis Ag's Income towards Parent Company fell 203.96% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.4 billion, marking a year-over-year increase of 1988.27%. This contributed to the annual value of $14.0 billion for FY2025, which is 1710.91% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Income towards Parent Company is $3.2 billion, which was down 203.96% from $4.2 billion recorded in Q3 2025.
  • Novartis Ag's Income towards Parent Company's 5-year high stood at $17.0 billion during Q4 2021, with a 5-year trough of $46.0 million in Q2 2023.
  • For the 5-year period, Novartis Ag's Income towards Parent Company averaged around $3.4 billion, with its median value being $3.2 billion (2021).
  • Per our database at Business Quant, Novartis Ag's Income towards Parent Company tumbled by 9910.92% in 2022 and then skyrocketed by 825000.0% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Income towards Parent Company stood at $17.0 billion in 2021, then tumbled by 99.11% to $151.0 million in 2022, then surged by 3768.87% to $5.8 billion in 2023, then tumbled by 43.77% to $3.3 billion in 2024, then decreased by 2.04% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q4 2025, $4.2 billion for Q3 2025, and $4.5 billion during Q2 2025.